Oral Oncology
Volume 46, Issue 3 , Pages 135-145, March 2010

Kaposi’s sarcoma of the head and neck: A review

  • Velia Ramírez-Amador

      Affiliations

    • Departamento de Atención a la Salud, Universidad Autónoma Metropolitana-Xochimilco, Calzada del Hueso 1100, Villa Quietud, México D.F., Mexico
    • Corresponding Author InformationCorresponding author. Address: Camino Sta. Teresa 277-9, Col. Parques del Pedergal, Mexico D.F. 14010, Mexico. Tel.: +52 (55) 5606 1781; fax: +52 (55) 5483 7206.
    • Tel.: +52 (55) 5483 7206.
  • ,
  • Gabriela Anaya-Saavedra

      Affiliations

    • Departamento de Atención a la Salud, Universidad Autónoma Metropolitana-Xochimilco, Calzada del Hueso 1100, Villa Quietud, México D.F., Mexico
    • Tel.: +52 (55) 5483 7206.
  • ,
  • Guillermo Martínez-Mata

      Affiliations

    • Facultad de Odontología, Universidad Autónoma de Chihuahua, Av. Escorza No. 900, Zona Centro CP 3100, Chihuahua, Mexico
    • Tel.: +52 (614) 439 1500.

Received 20 October 2009; received in revised form 17 December 2009; accepted 18 December 2009. published online 08 February 2010.

Summary 

Important advances in Kaposi’s sarcoma (KS) knowledge have been achieved, but KS is still a dilemma. It is an angioproliferative disorder classified as an intermediate neoplasm due to the absence of conventional clinical features of malignancy, but at the moment, it remains unclear if KS could be considered a reactive proliferation of endothelial cells and spindle cells, a true malignancy or both. In this review, the authors address the main epidemiological, clinical, and biological features, of the five types of KS, with emphasis on KS affecting the head and neck region. Also, a revision is done in relation with transmission, the role of saliva, and the pathogenic events associated with human herpesvirus type-8 (HHV-8). Treatment options are revised, highlighting the need for future approaches focused on targeting signaling pathways.

Keywords: Kaposi’s sarcoma, AIDS, HIV, Human herpesvirus-8, Oral, Head and neck, Saliva, Therapy, Pathogenesis, Clonality

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(09)01011-2

doi:10.1016/j.oraloncology.2009.12.006

Oral Oncology
Volume 46, Issue 3 , Pages 135-145, March 2010